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ABSTRACT. The malaria treatment recommended by the World 
Health Organization involves medicines derived from artemisinin, 
an active compound extracted from the plant Artemisia annua, and 
some of its derivatives, such as artesunate. Considering the lack of 
data regarding the genotoxic effects of these compounds in human 
cells, the objective of this study was to evaluate the cytotoxicity and 
genotoxicity, and expressions of the CASP3 and SOD1 genes in a 
cultured human hepatocellular liver carcinoma cell line (HepG2 cells) 
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treated with artemisinin and artesunate. We tested concentrations of 
2.5, 5, 7.5, 10, and 20 mg/mL of both substances with a resazurin 
cytotoxicity assay, and the concentrations used in the genotoxicity 
experiments (2.5, 5, and 10 mg/mL) and gene expression analysis 
(5 mg/mL) were determined. The results of the comet assay in cells 
treated with artemisinin and artesunate showed a significant dose-
dependent increase (P < 0.001) in the number of cells with DNA 
damage at all concentrations tested. However, the gene expression 
analysis revealed no significant change in expression of CASP3 or 
SOD1. Our data showed that although artemisinin and artesunate 
exhibited genotoxic effects in cultured HepG2 cells, they did not 
significantly alter expression of the CASP3 and SOD1 genes at the 
doses tested.
Key words: Artemisinin; Artesunate; HepG2 cells; Gene expression; 
Comet assay; CASP3 and SOD1 genes
INTRODUCTION
Many plant extracts and their active components have been described and utilized 
as therapeutic agents (Verma and Singh, 2008); however, some plants also synthesize 
toxic substances as a primary defense against hordes of bacteria, fungi, insects, and other 
predators. Therefore, it is important to assess the genotoxic effects and changes in gene 
expression caused by medicinal extracts and their isolated compounds.
Artemisinin, a natural sesquiterpene lactone isolated from the plant Artemisia an-
nua, is a widely used drug for treating resistant strains of malaria (Efferth et al., 2001). 
Artesunate is a semisynthetic derivative of artemisinin that has been accepted as a treat-
ment for malaria (Price, 2000). Artemisinin and its derivative compounds are present 
in all five of the combined therapies recommended by the World Health Organization 
(WHO) for the treatment of uncomplicated falciparum malaria (WHO, 2010).
Some in vitro studies using cancer cell lines suggested that artemisinin and some 
of its derivatives have cytotoxic effects, alter the cell cycle, and induce apoptosis (Hou et 
al., 2008; Li et al., 2008; Youns et al., 2009; Zhang et al., 2010). These compounds may 
present cytotoxic activity in mammal cell proliferation (Efferth et al., 2001; Disbrow et 
al., 2005), and it has been suggested that the toxicity is related to high intracellular con-
centrations of iron (Smith et al., 1997; Singh and Lai, 2001).
Other studies have indicated that the mechanism of action of antimalarial drugs, 
including artemisinin and its derivatives, causes damage to membrane structures, which 
can directly influence normal cell functioning and initiate a series of biochemical reac-
tions resulting in cell death (Olliaro and Taylor, 2004; Sato et al., 2007). In addition, 
it has been shown that endoperoxides of artemisinin trigger the production of reactive 
oxygen species (ROS), which has also been implicated in the mechanism of cytotoxicity 
(Disbrow et al., 2005). Embryotoxicity has been observed in rats and rabbits (Clark et al., 
2004; Longo et al., 2006), and neurotoxicity has been observed both in vitro and in vivo 
(Schmuck et al., 2002).
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Reports on mammalian cell genotoxicity are scarce for artesunate. Aquino et al. 
(2011) reported genotoxic effects of artesunate in liver cells of mice at low doses and clas-
togenic effects at high doses in bone marrow cells of the same animals. Li et al. (2008) and 
Mota et al. (2011) reported genotoxic and cytotoxic effects of artesunate in vitro in Chi-
nese hamster ovary cells and in human peripheral lymphocytes, respectively. To the best 
of our knowledge, no genotoxic studies on mammalian cells of artemisinin and no geno-
toxic studies on metabolizing cells of artemisinin and artesunate have been carried out.
Cell death is obligatory for harmonious cell life in animals for the removal of 
infected, injured, or cancerous cells, and caspases are usually involved in this apoptotic 
process (Denault and Salvesen, 2002). Considering that ROS play important roles in the 
pathogenesis of many diseases, and that superoxide dismutases (SODs) are the major an-
tioxidant defense systems against ROS (Fukai and Ushio-Fukai, 2011), it is important to 
evaluate expression of these genes when cells are exposed to new chemicals in order to 
better evaluate the cytotoxicity of these compounds.
Because artemisinin and artesunate are widely used drugs, with more than 100 
million doses administered annually (WHO, 2010), it is essential to develop studies exam-
ining their genotoxic potential and to determine the molecular mechanisms of their cyto-
toxicity in order to evaluate their safe and effective use for malaria and their potential use 
in cancer treatment. By exposing human hepatocellular liver carcinoma (HepG2) cells to 
artemisinin and artesunate in vitro, this study evaluated both the cytotoxic and genotoxic 
effects of these compounds on mammalian DNA, as well as expressions of the caspase 
3 (CASP3) and SOD1 genes to obtain more information about its genotoxic mechanism.
MATERIAL AND METHODS
Artemisinin and artesunate
The leaves of A. annua L. were collected in the experimental field of medicinal 
plants of Multidisciplinary Research Chemical, Biological and Agricultural Center 
(CPQBA) - UNICAMP - in the town of Paulínia, SP. A voucher specimen was deposited 
in the herbarium of CPQBA (CPQBA 12.46). Leaves (5000 g) of A. annua were oven 
dried at 40°C, pressed, and extracted by maceration with 20 L hexane for 2 days. The 
macerated sample was filtered and concentrated under reduced pressure, providing 92 
g crude extract hexane (1.84% yield). The artemisinin purification was conducted in 
chromatography columns using silica gel 60 230-400 mesh (0.040-0.063 mm particulates). 
Elution of sample components was achieved by incorporating the material with a mixture 
of n-hexane:ethyl acetate (9:1). The same mobile phase was used to run the column and 
the successive fractions obtained were monitored by thin layer chromatography. After 
purification of the sample, crystallization of the artemisinin was performed with selected 
solvents (Cafferata et al., 2009). Colorless crystals, with the typical characteristic of long 
needles, were obtained for a total of 16.4 g artemisinin (0.33% yield). The analysis was 
confirmed by nuclear magnetic resonance, whose spectra were obtained in a Bruker device 
DPX 400 MHz, operating at 400 MHz for [1H] and at 100 MHz to [13C]. The samples were 
dissolved in deuterated chloroform (CDCl3, Sigma-Aldrich Co.).
Dihydroartemisinin (DHA) was prepared from artemisinin using a routine proce-
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dure (Brossi et al., 1988). The chloride acid RCOCl was prepared from the corresponding 
carboxylic acids by heating with thionyl chloride at 55°C for 3 h and reacting with DHA 
in the presence of triethylamine in dry dichloromethane at 0°C for 2 h to furnish ester 
derivatives in 49-58% yields. Artesunate was prepared from DHA by reacting it with suc-
cinic acid anhydride in basic medium. Pyridine was used as the solvent, sodium bicarbon-
ate as the base, and N,N-dimethylaminopyridine and triethylamine in 1,2-dichloroethane 
were used as catalysts, with yields of up to 100%. The mixture was stirred for up to 9 h 
to obtain artesunate in quantitative yield. The product was further re-crystallized from di-
chloromethane. Alpha-artesunate was exclusively formed (melting point = 135°-137°C). 
The purity of both compounds was estimated at 99% by both high performance liquid 
chromatography and spectral data analysis.
Cell line
The human hepatoma cell line HepG2 used in our study was obtained from the 
Cell Bank of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil. Cells were cultivated in 
minimum essential media (Gibco) supplemented with 10% fetal bovine serum (Gibco) 
and antibiotics (Gibco), at 37°C, 5% CO2, and 95% relative humidity.
Cytotoxicity evaluation: resazurin-based assay
Since 1995, several studies have used resazurin as an indicator of cell viability (Yajko 
et al., 1995). In our experiments, we tested artemisinin and artesunate at concentrations 
chosen according to the available literature: 2.5, 5, 7.5, 10, and 20 mg/mL. The tests were 
done in biological duplicate with three repetitions each. Approximately 5 x 104 cells were 
seeded in each well of a 24-well microplate. After 24 h stabilization, cells were treated 
with the concentrations of artemisinin or artesunate described above, as well as with 2 mg/
mL doxorubicin as a positive control, for 24 h. At the end of this period, the medium was 
removed, cells were washed with phosphate-buffered saline, and cells were incubated with 
60 mM resazurin (Acros Organics) for 3 h. Fluorescence was measured with VICTOR 3 
(Perkin Elmer) at 530-560 nm of excitation and a 580-600-nm emission range.
Comet assay
The comet test was carried out based on conditions described in Tice et al. (2000). 
One million cells were seeded for each experimental flask and, after 24 h stabilization, 
they were treated with artemisinin or artesunate at concentrations of 2.5, 5, and 10 mg/mL 
for 3 h. The positive control concentration chosen was 2 mg/mL, since it requires metabo-
lization to exert genotoxic effects. After this, cells were trypsinized (500 mL 0.1% trypsin-
EDTA, 37°C), the cell suspension was centrifuged (5 min, 1000 rpm), and the pellet was 
resuspended in 500 mL culture medium. Next, 120 mL low melting point agarose (0.5%) 
was added to the cells, this mixture was deposited on pregelatinized slides (1.5% normal 
melting point agarose), and placed in lysis solution for at least 1 h. After denaturation (20 
min) and alkaline electrophoresis (25 V, 300 mA, 40 min), the slides were neutralized, 
fixed, and kept refrigerated until analysis. The slides were stained with ethidium bromide 
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and were analyzed visually (Kobayashi, 1995) under a fluorescence microscope (exci-
tation filter of 420-490 nm and emission filter of 520 nm) at 400X magnification. The 
comets were classified as follows: class 0, nucleus without tail; class 1, nucleus with tail 
less than the diameter of the nucleus; class 2, nucleus with tail 1 to 2 times the diameter 
of the nucleus; class 3, nucleus with tail more than 2 times the diameter of the nucleus. 
Experiments were performed in triplicate, and 300 cells were analyzed per treatment. De-
termination of cell viability was carried out by the trypan blue exclusion method, where 
only treatments with greater than 80% viability were considered.
Quantitative real-time polymerase chain reaction (qRT-PCR)
For analysis of gene expression, 106 cells were seeded in each experimental cul-
ture flask. After 24 h stabilization, cells were treated with 5 mg/mL artemisin or artesunate 
for 12 h. Experiments were performed in duplicate. 
Total RNA extraction was performed using the Trizol LS reagent (Invitrogen) ac-
cording to manufacturer instructions. DNAse I (Invitrogen) treatment was also performed 
according to manufacturer instructions. RNA quality was verified on agarose gel (28S and 
18S rRNA pattern of bands) and by the A260/A280 ratio. The cDNA was synthesized with 
10 pmol/mL oligo-dT primer and M-MLV reverse transcriptase (Invitrogen), and stored 
at -80°C until use in qRT-PCR experiments. qRT-PCR runs were performed in an Engine 
Opticon detection system (Bio-Rad) using the Platinum® SYBR® Green qPCR SuperMix-
UDG kit (Invitrogen) under the following conditions: 50°C for 1 min, 95°C for 3 min, 35 
cycles of 95°C for 20 s each, 60°C for 30 s, and 72°C for 20 s. The melting curve varied 
from 50 to 95°C, ready every 0.5°C. Data were normalized with the GAPDH primer 
(Sugaya et al., 2005), which was amplified in each run of PCR. The primer sequence 
of SOD1 was manufactured according to Ding et al. (2004) and the primer sequence of 
CASP3 was designed using the IDT tool available at http://www.idtdna.com/Scitools/
Applications/Primerquest: forward 5ꞌ- GTGCTACAATGCCCCTGGAT-3ꞌ and reverse 
5ꞌ-GCCCATTCATTTATTGCTTTCC-3ꞌ.
Statistical analysis
After verifying for normal distribution, data obtained from cytotoxicity and single 
cell gel electrophoresis assays were submitted to one-way analysis of variance (ANOVA) 
and the Tukey-Kramer multiple comparison test with the GraphPad Instat® software (ver-
sion 3.01). Results were considered to be statistically significant at P < 0.05. Gene ex-
pression levels investigated by qRT-PCR were determined according to the Pfaffl (2001) 
method using the REST-384 software (Pfaffl et al., 2002).
RESULTS
Cytotoxicity assay (resazurin)
Results of duplicate resazurin tests indicated that the 7.5, 10, and 20 mg/mL con-
centrations of artemisinin and artesunate were cytotoxic (Figure 1). Based on these data, 
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we chose concentrations of 2.5, 5, and 10 mg/mL for the comet assay, and a concentration 
of 5 mg/mL for the gene expression analysis.
Comet assay
Under the experimental conditions, groups treated with both artemisinin and arte-
sunate had more cells with DNA damage and higher damage scores relative to the negative 
control group at all three concentrations tested (P < 0.001) (Table 1). For both compounds, the 
majority of cells that suffered DNA damage showed light to medium damage (classes 1 and 2), 
with a minority showing severe damage (class 3). In general, artemisinin produced a greater 
number of cells with DNA damage classes 2 and 3 than did artesunate.
Analysis of expression levels of the CASP3 and SOD1 genes 
According to the gene expression analysis, all groups maintained RNA integrity with 
satisfactory quantity and purity. The qRT-PCR analysis was used to detect changes in ex-
pressions of the two studied genes. Expression of CASP3 was slightly increased relative to 
controls. On the other hand, there was an increase in the expression of SOD1 in cells treated 
with artemisinin and a decrease in cells treated with artesunate. Nevertheless, the observed 
differences were not statistically significant (Figure 2).
Figure 1. Cytotoxicity of artesunate (ART) and artemisinin (ATM) by the resazurin cytotoxicity assay. *Significantly 
different from the control (P < 0.001).
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Figure 2. Relative expression of mRNA for CASP3 and SOD1, quantified by real-time PCR in HepG2 cell line.
Treatments Total1                            Comet class   Scores
  0 1 2 3 
Control   9 91   8   1   0   10
 11 89   9   2   0   13
 13 87 10   2   1   17
  11 ± 2.0      13.3 ± 3.5
Artemisinin (2.5 μg/mL) 93   7 46 42   5 145
 90 10 46 37   7 141
 92   8 45 40   7 146
 91.6 ± 1.5*        144 ± 2.6*
Artemisinin (5 μg/mL) 90 10 42 35 13 151
 95   5 48 38   9 151
 91   9 41 39 11 152
    92 ± 2.6*      151.3 ± 0.5*
Artemisinin (10 μg/mL) 94   6 42 33 19 165
 96   4 46 37 13 159
 97   3 38 36 23 179
 95.6 ± 1.5*     167.6 ± 10*
Artesunate (2.5 μg/mL) 52 48 40 12   0   64
 62 38 48 14   0   76
 70 30 53 16   1   88
 61.3 ± 9.0*          76 ± 12*
Artesunate (5 μg/mL) 70 30 53 14   3   90
 64 36 38 23   3   93
 68 32 46 20   2   92
 67.3 ± 3.0*        91.6 ± 1.5*
Artesunate (10 μg/mL) 92   8 41 34 17 160
 94   6 31 43 20 177
 98   2 29 53 16 183
 94.6 ± 3.0*        173.3 ± 11.9*
Doxorubicin (2 μg/mL) 95   5 15 39 41 166
 91   9 29 46 16 169
 92   8 25 52 15 174
    91 ± 4.5*      169.6 ± 4.0*
Table 1. DNA migration in the comet assay for the assessment of genotoxicity of artemisinin and artesunate in 
HepG2 cells (after 3-h treatment).
*Significantly different from the negative control (P < 0.001). 1Total number of damaged cells (classes 1, 2, and 3).
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DISCUSSION
Many medicines and environmental factors can cause DNA damage, and experiments 
analyzing the consequences of exposure to harmful agents are of fundamental importance 
for the development of medicines and environmental health research. Thus, with respect to 
artemisinin and artesunate, the presence of a safe balance between their therapeutic and toxi-
cological effects should be verified.
A resazurin cytotoxicity assay was performed to determine the concentrations of arte-
misinin and artesunate to be tested in the present study. This assay is one of the most widely 
used methods and is the most sensitive test for detecting in vitro cytotoxicity (Fotakis and 
Timbrell, 2006). One of the advantages of this test is that it does not only assess cell death, but 
can also indicate inhibited cell growth, i.e., cytostatic effect. Our results showed that concen-
trations of 7.5, 10, and 20 mg/mL artemisinin and artesunate were cytotoxic to HepG2 cells 
after 24 h of exposure. Artesunate-induced changes in cell cycle kinetics were observed previ-
ously. Veerasubramanian et al. (2006) reported that artesunate, at concentrations lower than 
those used in the present study, could reduce the proliferation of cultured lymphocytes. Zhou 
and Feng (2005) reported that artesunate blocked the cell cycle during the G0/G1 phase in 
vascular smooth muscle cells from the aortas of mice. Electron microscopy of Panc-1, BxPC-
3, and CFPAC-1 pancreatic cancer cells treated with artesunate revealed organelle destruction 
and internal disorganization in mitochondria, i.e., selective cytotoxic activity (Du et al., 2010).
In the present study, because the concentrations of 2.5 and 5 mg/mL artemisinin and 
artesunate were not cytotoxic to HepG2 cells, we performed the comet assay to verify whether 
these concentrations caused DNA damage. Results showed that all three concentrations tested 
of artemisinin and artesunate caused damage in the genetic material of HepG2 cells (P < 
0.001), predominantly resulting in damage classes 1 and 2.
Reports on mammalian cell genotoxicity are scarce for artesunate, and are entirely 
lacking for artemisinin. Li et al. (2008) analyzed Chinese hamster ovary (CHO-9) and hamster 
lung fibroblast (V79-2) cell lines with the comet assay and verified that, in vitro, artesunate 
induced DNA damage and apoptosis. These authors also concluded that in mammalian cells, 
artesunate generated damage through direct or indirect oxidative stress, resulting in DNA 
strand breakage. Mota et al. (2011) also reported the genotoxicity of artesunate in human pe-
ripheral lymphocytes. The present study confirmed such genotoxicity in vitro for human me-
tabolizing cells, and further studies are necessary to determine whether the generation of ROS 
could be involved in the genotoxicity of artesunate. Artesunate also showed genotoxic effects 
in peripheral blood leukocytes and liver cells of mice in vivo (Aquino et al., 2011). Our find-
ings also agree with authors who assessed the genotoxic effects of other sesquiterpenes (Burin 
et al., 2001; Canalle et al., 2001; Al-Zubairi et al., 2010). In addition to causing DNA damage, 
the cytotoxicity of these substances, especially artemisinin, is due in part to the decreased ex-
pression of topoisomerase 2 (Youns et al., 2009), which is essential for cell proliferation and 
is expressed in dividing cells (Toyoda et al., 2008).
Using the MTT test, Hou et al. (2008) observed a significant reduction in cell viability 
in HepG2 cells treated with artemisinin and DHA (1-100 mM), with the percentage of viable 
cells ranging from 84.7 to 15.5% (P < 0.01 ) after 48 h of exposure. Also in this study, treating 
HepG2 cells with artemisinin at 10, 25, and 50 mM resulted in greater numbers of G1 phase 
cells (67.41, 70.72, and 69.21%, respectively), in comparison with untreated cells.
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Apoptosis is a key regulator of physiological growth control and tissue homeostasis 
regulation. The methods currently used in clinical oncology and chemotherapy or immuno-
therapy to bring about the death of tumor cells involve activating apoptosis signal transduc-
tion. Hou et al. (2008) reported that artemisinin and artesunate exerted the greatest cytotoxic-
ity on HepG2, inhibiting cell proliferation and inducing apoptosis by activating the CASP3 
gene. Other authors also observed similar effects for both of these compounds (Li et al., 
2008; Youns et al., 2009; Du et al., 2010; Zhang et al., 2010). We analyzed expression of the 
CASP3 gene in HepG2 cells after exposure to artemisinin and artesunate because it is the 
final common pathway of almost all apoptotic pathways. Both compounds caused a slight, 
although not statistically significant, increase in the expression of this gene, which may sug-
gest that they alter the cell cycle but do not induce apoptosis (Figure 2). This non-significant 
increase in CASP3 expression may also be due to exposure time (12 h). Youns et al. (2009) 
observed increased CASP3 expression in experiments with artemisinin, although cells were 
treated for 6 h.
Due to artemisinin and the relationship of artesunate with oxidative stress induction 
(Michaelis et al., 2010), we chose to study expression of Cu/Zn SOD1. SODs catalyze the 
dismutation of the superoxide radical O2 into hydrogen peroxide (H2O2) and elemental oxygen 
(O2), and thus provide an important defense against the toxicity of superoxide radicals. Our 
results showed that, compared to the control group, SOD1 expression increased in cells treated 
with artemisinin and decreased in those treated with artesunate, although these differences 
were not statistically significant. In a microarray analysis, Youns et al. (2009) also observed 
a slight decrease in expression of SOD1 after treating pancreatic cells with artesunate. Since 
only artemisinin treatment increased SOD1 expression, it is possible that this compound has 
a greater potential for generating oxidative stress than does artesunate. On the other hand, 
according to Effert et al. (2003) and Effert and Volm (2005), tumor cells can also present re-
sistance to artesunate due to induced expression of antioxidant genes. This hypothesis should 
be further investigated.
In conclusion, our results indicated that artemisinin and artesunate are potent geno-
toxic compounds in human HepG2 cells and that a concentration of 5 mg/mL of these com-
pounds was insufficient to produce significant alterations in CASP3 and SOD1 expressions. 
Therefore, based on our genotoxicity findings, caution regarding the intake of artemisinin and 
artesunate is necessary, since both may result in an increased risk of carcinogenesis.
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